New antibody treatment that makers claim can tackle omicron approved by UK regulator

Redirecting to full article in 5 second(s)...

Xevudy (sotrovimab), made by pharmaceutical giant GlaxoSmithKline (GSK), has been found to cut hospital admission and death by 79 percent